Johnson & Johnson vaccine given EU authorisation

Johnson & Johnson vaccine given EU authorisation
Credit: Belga

Johnson & Johnson’s coronavirus vaccine has become the latest approved for use in the EU after it was officially authorised today.

Taking to Twitter on Thursday Afternoon, Commission President Ursula von der Leyen announced the news of the vaccine approved for use in the EU.

This news comes after the European Medicines Agency (EMA) recommended granting conditional marketing authorisation for Johnson & Johnson’s coronavirus vaccine for people from 18 years old.

After evaluation, EMA concluded by consensus that the vaccine met the criteria for efficacy, safety and quality, the Agency said in a press release.

Following Pfizer/BioNtech, Moderna and AstraZeneca, Johnson & Johnson is now the fourth vaccine that has been recommended for use in the EU for preventing Covid-19.

This is the first vaccine that can be used as a single dose, which may give vaccination campaigns – including Belgium’s – a boost. Belgium ordered about 5 million doses of the vaccine, which could be delivered from early April. If everything goes according to plan, it could be administered from mid-April.

The Brussels Times

Related News


Latest News

Copyright © 2021 The Brussels Times. All Rights Reserved.